RE: MHC lab tests11 Jan 2024 20:59
I wouldn't be expecting anywhere near 10m in the bank by June. My guess is this will go into product development, advertising and IT & maybe an acquisition, as has been intimated last year. The cash position is likely to remain stable or go down. It's good that there is optimism here, but my view is to balance things out and I see headwinds ahead.
Traction doesn't necessarily mean things are going great - could mean they have sold one more test per week than they did the week before. Without sales volumes and margins, we are just at the mercy of the words they use in the RNS.
Also, there is too much reliance on Boots - there are other outlets. Putting all your eggs in virtually one basket is very risky.
But, I do hope they will do well in 2024 - lets see what happens.
Or a PE buyout may be on the cards, as I am sure it is not cost-effective letting this run as a public company what with the associated listing, regulatory and compliance costs that come with it eating into their cash.
DYOR